top of page

Our Objective

To support the timely adoption and scale-up of new TB diagnostics, we analyzed the introduction pathways in 9 high TB-burden countries. This project focused on mapping key steps, from global and national regulatory approval to national scale-up, for innovations such as tongue swabs, POC NATs, distributable PCR kits, and novel screening tools. Through this critical path analysis, we aim to share country-specific roadmaps and provide guidance to manufacturers and global stakeholders on regulatory processes, evidence requirements, and key enablers for successful implementation.

Meet The Team

Team Leads
Africa

Team Leads
Asia

Team Members

Contact Us

McGill International TB Centre
Research Institute of the McGill University Health Centre
5252, boul.de Maisonneuve West
Montreal, Quebec, H4A 3S5 Canada

Pai_McGill TB logo_FINAL (2) transp.png
bottom of page